709 related articles for article (PubMed ID: 12535959)
41. Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus.
Sands SA; Morilak DA
Neuroscience; 1999; 91(2):639-49. PubMed ID: 10366021
[TBL] [Abstract][Full Text] [Related]
42. Lack of decrease in hypothalamic and hippocampal glucocorticoid receptor mRNA during starvation.
Makino S; Kaneda T; Nishiyama M; Asaba K; Hashimoto K
Neuroendocrinology; 2001 Aug; 74(2):120-8. PubMed ID: 11474219
[TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
[TBL] [Abstract][Full Text] [Related]
44. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors.
Herman JP; Dolgas CM; Carlson SL
Neuroscience; 1998 Sep; 86(2):449-59. PubMed ID: 9881860
[TBL] [Abstract][Full Text] [Related]
45. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
Makino S; Smith MA; Gold PW
Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
[TBL] [Abstract][Full Text] [Related]
46. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha.
Hayley S; Staines W; Merali Z; Anisman H
Neuroscience; 2001; 106(1):137-48. PubMed ID: 11564424
[TBL] [Abstract][Full Text] [Related]
47. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy.
Palkovits M; Young WS; Kovács K; Tóth Z; Makara GB
Neuroscience; 1998 Jul; 85(1):135-47. PubMed ID: 9607709
[TBL] [Abstract][Full Text] [Related]
48. Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat.
Corchero J; Manzanares J; Fuentes JA
Neuropharmacology; 1999 Mar; 38(3):433-9. PubMed ID: 10219981
[TBL] [Abstract][Full Text] [Related]
49. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
[TBL] [Abstract][Full Text] [Related]
50. Neurotoxic lesions induced by monosodium glutamate result in increased adenopituitary proopiomelanocortin gene expression and decreased corticosterone clearance in rats.
Skultétyová I; Kiss A; Jezová D
Neuroendocrinology; 1998 Jun; 67(6):412-20. PubMed ID: 9662721
[TBL] [Abstract][Full Text] [Related]
51. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
Laflamme N; Bovetto S; Richard D; Rivest S
Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
[TBL] [Abstract][Full Text] [Related]
52. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint.
Zelena D; Mergl Z; Foldes A; Kovács KJ; Tóth Z; Makara GB
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1110-7. PubMed ID: 14534078
[TBL] [Abstract][Full Text] [Related]
53. A single lipopolysaccharide administration is sufficient to induce a long-term desensitization of the hypothalamic-pituitary-adrenal axis.
Vallès A; Martí O; Harbuz MS; Armario A
Neuroscience; 2002; 112(2):383-9. PubMed ID: 12044455
[TBL] [Abstract][Full Text] [Related]
54. Differential neuroendocrine responses to chronic variable stress in adult Long Evans rats exposed to handling-maternal separation as neonates.
Ladd CO; Thrivikraman KV; Huot RL; Plotsky PM
Psychoneuroendocrinology; 2005 Jul; 30(6):520-33. PubMed ID: 15808921
[TBL] [Abstract][Full Text] [Related]
55. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
56. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
Herman JP; Wiegand SJ; Watson SJ
Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
[TBL] [Abstract][Full Text] [Related]
57. Stress-induced alterations in corticotropin-releasing hormone and vasopressin gene expression in the paraventricular nucleus during ontogeny.
Dent GW; Okimoto DK; Smith MA; Levine S
Neuroendocrinology; 2000 Jun; 71(6):333-42. PubMed ID: 10878495
[TBL] [Abstract][Full Text] [Related]
58. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress.
Makino S; Asaba K; Nishiyama M; Hashimoto K
Neuroendocrinology; 1999 Sep; 70(3):160-7. PubMed ID: 10516478
[TBL] [Abstract][Full Text] [Related]
59. Intravenous administration of interleukin-1 beta induces Fos-like immunoreactivity in corticotropin-releasing hormone neurons in the paraventricular hypothalamic nucleus of the rat.
Veening JG; van der Meer MJ; Joosten H; Hermus AR; Rijnnkels CE; Geeraedts LM; Sweep CG
J Chem Neuroanat; 1993; 6(6):391-7. PubMed ID: 8142074
[TBL] [Abstract][Full Text] [Related]
60. Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level.
de la Tremblaye PB; Raymond J; Milot MR; Merali Z; Plamondon H
Horm Behav; 2014 Mar; 65(3):273-84. PubMed ID: 24444675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]